Home › Trial NCT06385990
Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy
- Trial IDNCT06385990
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorHunan Cancer Hospital
- Enrollment53
- Start date2024-03-29
- ConditionsTriple Negative Breast Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.